Position in MNKD
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$8,870,011
-$33,521,715 QoQ
Shares Held
3,620,413
-51.6% QoQ
Ownership
1.17%
of shares outstanding
% of Portfolio
0.11%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2025
3 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in MNKD Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Rubric Capital Management LP holds $938,577,278 across 18 Biotechnology names. MNKD ranks #15 (0.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ARQT |
Arcutis Biotherapeutics, Inc.
|
8,271,577 | $194,878,354 | |
| 2 | ZYME |
Zymeworks Inc.
|
7,000,000 | $175,280,000 | |
| 3 | ROIV |
Roivant Sciences Ltd.
|
5,000,000 | $138,500,000 | |
| 4 | SPRY |
ARS Pharmaceuticals, Inc.
|
8,000,000 | $64,240,000 | |
| 5 | MGTX |
MeiraGTx Holdings plc
|
7,000,000 | $60,620,000 | |
| 6 | PRTA |
Prothena Corp Public Ltd Co
|
5,000,000 | $48,600,000 | |
| 7 | PTGX |
Protagonist Therapeutics, Inc
|
427,998 | $45,110,989 | |
| 8 | TRVI |
Trevi Therapeutics, Inc.
|
3,712,373 | $44,288,609 |
All Filings in MNKD
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $8,870,011 | 3,620,413 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $42,391,726 | 7,476,495 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $61,296,783 | 11,414,671 | Shares | Sole | 2025-11-14 | |
| No filing history on record for this holder in this stock. | ||||||